Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00377247 · ClinicalTrials.gov registry record · Phase 1
Active Immunization of Patients With Carcinoma of Oral Cavity or Oropharynx With Autologous Dendritic Cells Transfected With DNA From Autologous Tumor
A Phase 1 study, sponsored by University of Pittsburgh.
- Terminated
- Registry status
- Phase 1
- Development phase
- 5
- Enrollment target
NCT00377247 is a Phase 1 study that was terminated before completion, run by University of Pittsburgh. The registered enrollment target is 5 participants.
The verdict
NCT00377247, a Phase 1 study, was terminated before completion, sponsored by University of Pittsburgh.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 5 participants
- Enrollment target
Study Summary
The primary goal of this study is to determine if the vaccine can be safely given to subjects, and to see what side effects occur (both good and bad) when they are given this experimental tumor vaccine. During this study, investigators intend to watch for tumor response while examining the effects of this vaccine on the body's immune system after it is given.
Interventions
- BIOLOGICAL autologous monocyte-derived dendritic cells (DC) transfected with DNA
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2009-04 |
| Est. Completion | 2009-04 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00377247
The ClinicalTrials.gov registry entry for NCT00377247 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which autologous monocyte-derived dendritic cells (DC) transfected with DNA is the first listed.
NCT00377247 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00377247 about?
NCT00377247 is a clinical study titled "Active Immunization of Patients With Carcinoma of Oral Cavity or Oropharynx With Autologous Dendritic Cells Transfected With DNA From Autologous Tumor". The primary goal of this study is to determine if the vaccine can be safely given to subjects, and to see what side effects occur (both good and bad) when they are given this experimental tumor vaccine. During this study, investigators intend to watch for tumor response while examining the effects o...
What is the current status of trial NCT00377247?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 5 participants. The study started on 2009-04. Estimated completion is 2009-04.
What interventions are being tested in trial NCT00377247?
The interventions under investigation include: autologous monocyte-derived dendritic cells (DC) transfected with DNA (BIOLOGICAL).
Who is sponsoring clinical trial NCT00377247?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.